CA2081068C
(fr)
*
|
1991-10-23 |
2005-11-29 |
Laurence Mark Von Itzstein |
Derives antiviraux de 2-desoxy-2,3-deshydro a substituant en 4 de l'acide .alpha.-d-neuraminique
|
GB9126725D0
(en)
*
|
1991-12-17 |
1992-02-12 |
Glaxo Group Ltd |
Process
|
GB9220241D0
(en)
*
|
1992-09-25 |
1992-11-11 |
Glaxo Group Ltd |
Process
|
GB9220327D0
(en)
*
|
1992-09-25 |
1992-11-11 |
Glaxo Group Ltd |
Process
|
GB9312531D0
(en)
*
|
1993-06-17 |
1993-08-04 |
Glaxo Group Ltd |
Process
|
US5958973A
(en)
*
|
1993-09-03 |
1999-09-28 |
Gilead Sciences, Inc. |
Polyhydroxy benzoic acid derivatives and their use as neuraminidase inhibitors
|
GB9325841D0
(en)
|
1993-12-17 |
1994-02-23 |
Glaxo Group Ltd |
Chemical compounds
|
GB9400206D0
(en)
*
|
1994-01-07 |
1994-03-02 |
Glaxo Group Ltd |
Chemical compound
|
AUPM354694A0
(en)
*
|
1994-01-27 |
1994-02-17 |
Biota Scientific Management Pty Ltd |
Chemical compounds
|
US5453533A
(en)
*
|
1994-04-14 |
1995-09-26 |
The University Of Alabama At Birmingham |
Inhibitors of influenza virus neuraminidase and methods of making and using the same
|
US5985859A
(en)
*
|
1994-04-14 |
1999-11-16 |
The University Of Alabama |
Methods of inhibiting bacterial sialidase
|
WO1995032955A1
(fr)
*
|
1994-05-27 |
1995-12-07 |
Daikin Industries, Ltd. |
Acide 7-fluoro-2, 3-didehydrosialique et intermediaire pour la synthese de cet acide
|
GB9410817D0
(en)
*
|
1994-05-28 |
1994-07-20 |
Glaxo Group Ltd |
Medicaments
|
AUPM725794A0
(en)
*
|
1994-08-03 |
1994-08-25 |
Biota Scientific Management Pty Ltd |
Chemical compounds
|
US5556963A
(en)
*
|
1994-08-05 |
1996-09-17 |
Oklahoma Medical Research Foundation |
Synthesis of 4-alkoxy-N-acetylneuraminic acid
|
GB9416365D0
(en)
*
|
1994-08-12 |
1994-10-05 |
Glaxo Group Ltd |
Medicaments
|
US5512596A
(en)
*
|
1994-09-02 |
1996-04-30 |
Gilead Sciences, Inc. |
Aromatic compounds
|
US5475109A
(en)
*
|
1994-10-17 |
1995-12-12 |
Merck & Co., Inc. |
Dioxobutanoic acid derivatives as inhibitors of influenza endonuclease
|
DK0976734T3
(da)
*
|
1995-02-27 |
2005-12-27 |
Gilead Sciences Inc |
Selektive inhibitorer af viral eller bakteriel neuraminidase
|
CN101143859A
(zh)
*
|
1995-02-27 |
2008-03-19 |
吉里德科学公司 |
新颖化合物,其合成方法及治疗用途
|
DE759917T1
(de)
|
1995-02-27 |
1998-10-22 |
Gilead Sciences Inc |
Neue selektive inhibitoren viraler oder bakterieller neuraminidasen
|
AU4259500A
(en)
*
|
1995-02-27 |
2000-08-31 |
Gilead Sciences, Inc. |
Novel compounds and methods for synthesis and therapy
|
US5866601A
(en)
*
|
1995-02-27 |
1999-02-02 |
Gilead Sciences, Inc. |
Carbocyclic compounds
|
US5602277A
(en)
*
|
1995-03-30 |
1997-02-11 |
Biocryst Pharmaceuticals, Inc. |
Substituted benzene derivatives useful as neuraminidase inhibitors
|
US5714509A
(en)
*
|
1995-05-03 |
1998-02-03 |
The University Of Alabama |
Inhibitors of bacterial sialidase and methods of making and using the same
|
HUP9801766A3
(en)
*
|
1995-05-19 |
2000-09-28 |
Biota Scient Managemant Pty Lt |
6-carboxamido dihydropyran derivatives, process for producing them and medicaments containing the same
|
GB9516276D0
(en)
*
|
1995-08-08 |
1995-10-11 |
Biota Scient Management |
Chemical compounds
|
JPH0967270A
(ja)
*
|
1995-08-31 |
1997-03-11 |
Res Dev Corp Of Japan |
水晶体混濁の予防および治療法、並びにそのための薬 剤
|
US5763483A
(en)
*
|
1995-12-29 |
1998-06-09 |
Gilead Sciences, Inc. |
Carbocyclic compounds
|
DE69721242T2
(de)
*
|
1996-03-01 |
2004-01-29 |
Biota Scient Management |
Verfahren zum nachweis von influenza-virus und dazu verwendbare verbindungen
|
US6093816A
(en)
|
1996-06-27 |
2000-07-25 |
Isis Pharmaceuticals, Inc. |
Cationic lipids
|
US6340702B1
(en)
|
1996-07-22 |
2002-01-22 |
Sankyo Company, Limited |
Neuraminic acid derivatives, their preparation and their medical use
|
US6451766B1
(en)
|
1996-07-22 |
2002-09-17 |
Sankyo Company, Limited |
Neuraminic acid derivatives, their preparation and their medical use
|
ES2167682T3
(es)
*
|
1996-07-22 |
2002-05-16 |
Sankyo Co |
Derivados del acido neuraminico, su preparacion y su uso medico.
|
CZ293041B6
(cs)
*
|
1996-08-13 |
2004-01-14 |
Sankyo Company Limited |
Sloučeniny kyseliny neuraminové
|
US6518438B2
(en)
|
1996-08-23 |
2003-02-11 |
Gilead Sciences, Inc. |
Preparation of cyclohexene carboxylate derivatives
|
US5859284A
(en)
*
|
1996-08-23 |
1999-01-12 |
Gilead Sciences, Inc. |
Preparation of carbocyclic compounds
|
AU711845B2
(en)
*
|
1996-09-10 |
1999-10-21 |
Daikin Industries, Ltd. |
4-substituted-2,7-dideoxy-7-fluoro-2,3-didehydro-sialic acid compounds
|
US5719020A
(en)
*
|
1996-09-25 |
1998-02-17 |
Oklahoma Medical Research Foundation |
4,7-dialkoxy N-acetylneuraminic acid derivatives and methods for detection of influenza type A and B viruses in clinical specimens
|
US5994377A
(en)
|
1996-10-21 |
1999-11-30 |
Gilead Sciences, Inc. |
Piperidine compounds
|
WO1998017647A1
(fr)
*
|
1996-10-21 |
1998-04-30 |
Gilead Sciences, Inc. |
Composes de piperidine
|
AU732916C
(en)
|
1996-11-14 |
2002-06-06 |
Biota Scientific Management Pty Ltd |
Method and novel compounds for use therein
|
US5886213A
(en)
*
|
1997-08-22 |
1999-03-23 |
Gilead Sciences, Inc. |
Preparation of carbocyclic compounds
|
JP3390965B2
(ja)
|
1997-09-12 |
2003-03-31 |
理化学研究所 |
糖結合スフィンゴシンを含有するポリマー化合物
|
ID25516A
(id)
*
|
1997-09-17 |
2000-10-05 |
Gilead Sciences Inc |
Senyawa-senyawa yang mengandung cincin-cincin beranggotakan enam, proses pembuatannya, dan penggunaannya sebagai obat
|
US20040053999A1
(en)
*
|
1997-09-17 |
2004-03-18 |
Bischofberger Norbert W. |
Novel compounds and methods for synthesis and therapy
|
US20030129146A1
(en)
*
|
1997-10-31 |
2003-07-10 |
Vincent Fischetti |
The use of bacterial phage associated lysing proteins for treating bacterial dental caries
|
TW477783B
(en)
*
|
1997-12-12 |
2002-03-01 |
Gilead Sciences Inc |
Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same
|
US6518305B1
(en)
|
1998-04-23 |
2003-02-11 |
Abbott Laboratories |
Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
|
US6455571B1
(en)
|
1998-04-23 |
2002-09-24 |
Abbott Laboratories |
Inhibitors of neuraminidases
|
EP1087938A1
(fr)
*
|
1998-04-23 |
2001-04-04 |
Abbott Laboratories |
Inhibiteurs de neuraminidases
|
CN1309659A
(zh)
|
1998-07-15 |
2001-08-22 |
哈桑·朱马 |
有机磷化合物及其用途
|
US6303764B1
(en)
|
1998-09-24 |
2001-10-16 |
Zymetx, Inc. |
Synthesis of 4,7-dialkyl chromogenic glycosides of N-acetylneuraminic acids
|
US6664235B1
(en)
|
1999-08-20 |
2003-12-16 |
Riken |
Medicaments comprising sialic acid derivatives as active ingredients
|
US6420552B1
(en)
|
1999-09-10 |
2002-07-16 |
Zymetx, Inc. |
Syntheses of 4-alkyl chromogenic glycosides and 7-alkyl chromogenic glycosides of N-acetylneuraminic acids
|
US6593314B1
(en)
|
1999-10-19 |
2003-07-15 |
Abbott Laboratories |
Neuraminidase inhibitors
|
WO2001029020A2
(fr)
*
|
1999-10-19 |
2001-04-26 |
Abbott Laboratories |
Inhibiteurs de la neuraminidase
|
US6627396B1
(en)
|
1999-10-28 |
2003-09-30 |
The Regents Of The University Of California |
Influenza sensor
|
US6733743B2
(en)
|
2000-03-06 |
2004-05-11 |
University Of Kentucky Research Foundation |
Methods to impair hematologic cancer progenitor cells and compounds related thereto
|
GB0015324D0
(en)
*
|
2000-06-22 |
2000-08-16 |
Biota Scient Management |
Medicaments
|
AUPR001000A0
(en)
|
2000-09-08 |
2000-10-05 |
Biota Scientific Management Pty Ltd |
Novel chemical compounds and their use
|
US20030096281A1
(en)
*
|
2001-09-14 |
2003-05-22 |
Ganesh Venkataraman |
Methods of making glycomolecules with enhanced activities and uses thereof
|
JP2006241024A
(ja)
*
|
2005-03-01 |
2006-09-14 |
Takashi Suzuki |
新規シアル酸誘導体
|
AR060623A1
(es)
|
2006-04-27 |
2008-07-02 |
Astrazeneca Ab |
Compuestos derivados de 2-azetidinona y un metodo de preparacion
|
CN100471848C
(zh)
*
|
2006-06-05 |
2009-03-25 |
中国医学科学院医药生物技术研究所 |
一组长链烷氧烷基取代唾液酸衍生物及其制备方法
|
US20080063722A1
(en)
*
|
2006-09-08 |
2008-03-13 |
Advanced Inhalation Research, Inc. |
Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)
|
JP5345073B2
(ja)
|
2007-01-23 |
2013-11-20 |
テラピコン エス.アール.エル. |
抗ウイルス化合物
|
US20080194801A1
(en)
*
|
2007-02-14 |
2008-08-14 |
Swanson Basil I |
Robust multidentate ligands for diagnosis and anti-viral drugs for influenza and related viruses
|
US7981930B2
(en)
*
|
2007-03-13 |
2011-07-19 |
Adamas Pharmaceuticals, Inc. |
Compositions and kits for treating influenza
|
US7960139B2
(en)
|
2007-03-23 |
2011-06-14 |
Academia Sinica |
Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
|
BRPI0810471A2
(pt)
|
2007-04-16 |
2014-11-11 |
Momenta Pharmaceuticals Inc |
Produtos de glicoproteína definidos e métodos relacionados
|
KR101535691B1
(ko)
*
|
2007-08-31 |
2015-07-09 |
아카데미아 시니카 |
항인플루엔자 활성을 갖는 포스포네이트 동종체를 함유하는 오셀타미비르의 합성
|
EP2276479B1
(fr)
|
2008-04-15 |
2014-07-02 |
SineVir Therapeutics LLC |
Promédicaments d'inhibiteurs de la neuraminidase
|
EP2318832B1
(fr)
|
2008-07-15 |
2013-10-09 |
Academia Sinica |
Matrices de glycane sur des lames de verre revêtues d' aluminium de type ptfe et procédés associés
|
ES2507492T3
(es)
|
2008-11-28 |
2014-10-15 |
Cipla Limited |
Proceso para preparar zanamivir e intermedios para uso en el proceso
|
TWI491416B
(zh)
|
2008-12-24 |
2015-07-11 |
Daiichi Sankyo Co Ltd |
吸入用乾燥粉末醫藥組成物
|
EP2228054A1
(fr)
|
2009-03-13 |
2010-09-15 |
ITALFARMACO S.p.A. |
Suspensions aqueuses au riluzole
|
WO2010127443A1
(fr)
*
|
2009-05-04 |
2010-11-11 |
National Research Council Of Canada |
Inhibiteurs de la sialidase ou d'enzymes analogues à la sialidase
|
CN102459169B
(zh)
|
2009-05-15 |
2014-12-31 |
莱德克斯制药有限公司 |
氧化还原药物衍生物
|
EP2454268B1
(fr)
|
2009-07-15 |
2014-09-10 |
The University Of British Columbia |
Glycosides 2,3-fluorés en tant qu'inhibiteurs de neuraminidase et leur utilisation en tant qu'agents antiviraux
|
JP2012532894A
(ja)
*
|
2009-07-16 |
2012-12-20 |
グリフィス ユニバーシティ |
抗インフルエンザ薬
|
IT1396620B1
(it)
|
2009-11-25 |
2012-12-14 |
Therapicon Srl |
Analoghi chimerici
|
US10087236B2
(en)
|
2009-12-02 |
2018-10-02 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
US11377485B2
(en)
|
2009-12-02 |
2022-07-05 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
JP2011136964A
(ja)
*
|
2009-12-28 |
2011-07-14 |
Gifu Univ |
ノイラミン酸誘導体、シアリダーゼ活性阻害剤及び抗インフルエンザ薬
|
US9921210B2
(en)
|
2010-04-07 |
2018-03-20 |
Momenta Pharmaceuticals, Inc. |
High mannose glycans
|
WO2011130332A1
(fr)
|
2010-04-12 |
2011-10-20 |
Academia Sinica |
Puces au glycane pour la recherche par criblage haut débit de virus
|
JP5947289B2
(ja)
|
2010-05-10 |
2016-07-06 |
アカデミア シニカAcademia Sinica |
抗インフルエンザ活性を有するザナミビルホスホネート同族体およびインフルエンザウイルスのオセルタミビルに対する感受性の決定
|
CN101921251B
(zh)
*
|
2010-09-21 |
2011-10-05 |
仙居县圃瑞药业有限公司 |
扎那米韦中间体的精制工艺方法
|
CN102464640A
(zh)
*
|
2010-10-29 |
2012-05-23 |
江苏正大天晴药业股份有限公司 |
扎那米韦的制备方法
|
AT510585B1
(de)
|
2010-11-18 |
2012-05-15 |
Apeptico Forschung & Entwicklung Gmbh |
Zusammensetzung umfassend ein peptid und ein hemmstoff der viralen neuraminidase
|
US20140073804A1
(en)
|
2011-02-24 |
2014-03-13 |
Ganpat Dan Shimbhu CHARAN |
Process for the preparation of zanamivir
|
WO2012125553A2
(fr)
|
2011-03-12 |
2012-09-20 |
Momenta Pharmaceuticals, Inc. |
N-glycanes contenant de la n-acétylhexosamine dans des produits de glycoprotéines
|
WO2012142492A2
(fr)
*
|
2011-04-15 |
2012-10-18 |
University Of Georgia Research Foundation, Inc. |
Procédés permettant d'inhiber la réplication de virus
|
KR101369584B1
(ko)
|
2011-04-19 |
2014-03-06 |
일양약품주식회사 |
페닐-이속사졸 유도체 및 그의 제조방법
|
WO2013093458A2
(fr)
|
2011-12-21 |
2013-06-27 |
Redx Pharma Limited |
Dérivés de médicament antiviraux
|
CN107954963A
(zh)
|
2012-01-19 |
2018-04-24 |
不列颠哥伦比亚大学 |
3’平伏氟取代的神经氨酸酶抑制剂化合物、组合物及其用作抗病毒剂的方法
|
US10130714B2
(en)
|
2012-04-14 |
2018-11-20 |
Academia Sinica |
Enhanced anti-influenza agents conjugated with anti-inflammatory activity
|
WO2013181575A2
(fr)
|
2012-06-01 |
2013-12-05 |
Momenta Pharmaceuticals, Inc. |
Méthodes associées au denosumab
|
EP2885311B1
(fr)
|
2012-08-18 |
2020-01-01 |
Academia Sinica |
Sondes perméables aux cellules pour l'identification et l'imagerie de sialidases
|
KR102186030B1
(ko)
|
2012-10-29 |
2020-12-03 |
시플라 리미티드 |
항 바이러스성 포스포네이트 유사체 및 이의 제조를 위한 방법
|
US10450361B2
(en)
|
2013-03-15 |
2019-10-22 |
Momenta Pharmaceuticals, Inc. |
Methods related to CTLA4-Fc fusion proteins
|
US10464996B2
(en)
|
2013-05-13 |
2019-11-05 |
Momenta Pharmaceuticals, Inc. |
Methods for the treatment of neurodegeneration
|
US10086054B2
(en)
|
2013-06-26 |
2018-10-02 |
Academia Sinica |
RM2 antigens and use thereof
|
WO2014210564A1
(fr)
|
2013-06-27 |
2014-12-31 |
Academia Sinica |
Conjugués de glycane et leur utilisation
|
CN103396957B
(zh)
*
|
2013-07-11 |
2015-08-19 |
中国海洋大学 |
一种来源于鲤链霉菌的海洋微生物多糖及其制备方法
|
KR102298172B1
(ko)
|
2013-09-06 |
2021-09-06 |
아카데미아 시니카 |
변화된 글리코실 그룹을 갖는 당지질을 사용한 인간 iNKT 세포 활성화
|
CN111116533B
(zh)
*
|
2013-09-09 |
2022-11-22 |
中国科学院上海有机化学研究所 |
扎那米韦和拉那米韦的中间体及其合成方法
|
EP3058084A4
(fr)
|
2013-10-16 |
2017-07-05 |
Momenta Pharmaceuticals, Inc. |
Glycoprotéines sialylées
|
JP6453050B2
(ja)
*
|
2013-11-15 |
2019-01-16 |
国立大学法人富山大学 |
2−デオキシ−2,3−ジデヒドロシアル酸誘導体およびその製造法
|
US10150818B2
(en)
|
2014-01-16 |
2018-12-11 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
EP3094352B1
(fr)
|
2014-01-16 |
2020-09-23 |
Academia Sinica |
Compositions et méthodes pour traiter et détecter des cancers
|
US10023892B2
(en)
|
2014-05-27 |
2018-07-17 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
JP6562942B2
(ja)
|
2014-03-27 |
2019-08-28 |
アカデミア シニカAcademia Sinica |
反応性標識化合物およびその使用
|
AU2015260841A1
(en)
|
2014-05-12 |
2016-12-01 |
Glaxosmithkline Intellectual Property (No. 2) Limited |
Pharmaceutical compositions comprising danirixin for treating infectious diseases
|
US10118969B2
(en)
|
2014-05-27 |
2018-11-06 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
EP3149037A4
(fr)
|
2014-05-27 |
2018-01-10 |
Academia Sinica |
Glycoanticorps anti-her2 et leurs utilisations
|
TWI670078B
(zh)
|
2014-05-27 |
2019-09-01 |
中央研究院 |
抗cd20醣抗體及其用途
|
EP3154582A4
(fr)
|
2014-05-28 |
2018-01-10 |
Academia Sinica |
Glycoanticorps anti-thf-alpha et leurs utilisations
|
NL2013420B1
(en)
*
|
2014-09-05 |
2016-09-27 |
Univ Griffith |
Antiviral agents and uses thereof.
|
WO2016040369A2
(fr)
|
2014-09-08 |
2016-03-17 |
Academia Sinica |
Activation des cellules inkt humaines par des glycolipides
|
EP3210995B1
(fr)
|
2014-10-24 |
2022-03-30 |
PeptiDream Inc. |
Peptide de liaison à l'hémagglutinine
|
US9975965B2
(en)
|
2015-01-16 |
2018-05-22 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
US10495645B2
(en)
|
2015-01-16 |
2019-12-03 |
Academia Sinica |
Cancer markers and methods of use thereof
|
EP3789766A1
(fr)
|
2015-01-24 |
2021-03-10 |
Academia Sinica |
Nouveaux conjugués de glycane et leurs procédés d'utilisation
|
JP2019515876A
(ja)
|
2016-03-08 |
2019-06-13 |
アカデミア シニカAcademia Sinica |
N−グリカンおよびそのアレイのモジュール合成のための方法
|
TWI764917B
(zh)
|
2016-08-22 |
2022-05-21 |
醣基生醫股份有限公司 |
抗體、結合片段及使用方法
|
CN106520864A
(zh)
*
|
2016-09-28 |
2017-03-22 |
南京农业大学 |
一种酶法合成唾液酸类似物的方法及其应用
|
AU2018273411B2
(en)
*
|
2017-05-25 |
2022-12-01 |
The Governors Of The University Of Alberta |
Methods of preventing or treating atherosclerosis with inhibitors of specific isoenzymes of human neuraminidase
|
US20230218644A1
(en)
|
2020-04-16 |
2023-07-13 |
Som Innovation Biotech, S.A. |
Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus
|
WO2023119230A1
(fr)
|
2021-12-22 |
2023-06-29 |
L'oreal |
Compositions de modulation de la voie de coagulation et de la voie de nicotinamide-adénine dinucléotide et leurs procédés d'utilisation
|
US20250152545A1
(en)
|
2021-12-23 |
2025-05-15 |
Subintro Limited |
Novel antiviral compositions comprising oleic acid
|